Overview

Treatment of Neuroleptic Induced Acute Akathisia With Trazodone

Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
Administration of trazodone for the treatment of neuroleptic induced acute akathisia in a cross-over fashion of 6 days duration. 3 days of placebo and 3 days of trazodone.
Phase:
Phase 4
Details
Lead Sponsor:
BeerYaakov Mental Health Center
Treatments:
Trazodone